Literature DB >> 18246440

Benign prostatic hyperplasia: dietary and metabolic risk factors.

H Nandeesha1.   

Abstract

Benign prostatic hyperplasia (BPH) is the most common nonmalignant condition of the prostate occurring in ageing men. Even though BPH is a major public health problem, causing high morbidity and substantial worsening in men's quality of life, little is known about its risk factors. Several studies revealed that it is a multifactorial disease. Previous studies have documented family history, hormonal imbalance, and growth factors as etiological factors in the development of BPH. This review focuses on the dietary and metabolic risk factors including diabetes mellitus, hypertension, obesity, hyperinsulinemia, as well as dyslipidemia and their mechanisms in the pathogenesis of BPH.

Entities:  

Mesh:

Year:  2008        PMID: 18246440     DOI: 10.1007/s11255-008-9333-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  60 in total

1.  Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia.

Authors:  Sadao Suzuki; Elizabeth A Platz; Ichiro Kawachi; Walter C Willett; Edward Giovannucci
Journal:  Am J Clin Nutr       Date:  2002-04       Impact factor: 7.045

2.  [Association study between benign prostatic hyperplasia and primary hypertension].

Authors:  Li-jun Guo; Xiang-hua Zhang; Pei-jun Li; Yan-qun Na
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2005-01-15

Review 3.  Phytoestrogens and diseases of the prostate gland.

Authors:  K Griffiths; L Denis; A Turkes; M S Morton
Journal:  Baillieres Clin Endocrinol Metab       Date:  1998-12

4.  Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Authors:  M C Michel; L Mehlburger; H Schumacher; H U Bressel; M Goepel
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

5.  Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

Authors:  J Hammarsten; B Högstedt
Journal:  Eur Urol       Date:  2001-02       Impact factor: 20.096

6.  Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids.

Authors:  T Liang; S Liao
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

7.  [Impact of hypertension on angiogenesis in the tissues of benign prostatic hyperplasia].

Authors:  Li-jun Guo; Xiang-hua Zhang; Pei-jun Li; Yan-qun Na
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2005-03-09

8.  Fatty acid composition of phospholipids in epithelium and stroma of human benign prostatic hyperplasia.

Authors:  H Weisser; M Krieg
Journal:  Prostate       Date:  1998-09-01       Impact factor: 4.104

9.  [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].

Authors:  Fu-li Wang; He Wang; Wei-jun Qin; Guo-jun Wu; Geng Zhang; Kai-nan Li
Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi       Date:  2004-03

10.  High-risk group for benign prostatic hypertrophy.

Authors:  H Araki; H Watanabe; T Mishina; M Nakao
Journal:  Prostate       Date:  1983       Impact factor: 4.104

View more
  13 in total

Review 1.  Role of interleukins, IGF and stem cells in BPH.

Authors:  Ian D McLaren; Travis J Jerde; Wade Bushman
Journal:  Differentiation       Date:  2011-08-23       Impact factor: 3.880

2.  Comparative study of frequency of different lymphocytes subpopulation in peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.

Authors:  Stanislav Sotosek; Vlatka Sotosek Tokmadzic; Ines Mrakovcic-Sutic; Maja Ilic Tomas; Marin Dominovic; Vera Tulic; Ivana Sutic; Antun Maricic; Jadranko Sokolic; Alan Sustic
Journal:  Wien Klin Wochenschr       Date:  2011-11-23       Impact factor: 1.704

3.  Effect of obesity and hyperglycemia on benign prostatic hyperplasia in elderly patients with newly diagnosed type 2 diabetes.

Authors:  Zhe Chen; Li Miao; Xia Gao; Guang Wang; Yuan Xu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 4.  A review of the anticancer potential of the antimalarial herbal cryptolepis sanguinolenta and its major alkaloid cryptolepine.

Authors:  C Ansah; K B Mensah
Journal:  Ghana Med J       Date:  2013-09

Review 5.  Insulin: a novel agent in the pathogenesis of prostate cancer.

Authors:  Hanumanthappa Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-07-30       Impact factor: 2.370

6.  Effects of obesity on prostate volume and lower urinary tract symptoms in korean men.

Authors:  Geun Woo Kim; Seung Whan Doo; Won Jae Yang; Yun Seob Song
Journal:  Korean J Urol       Date:  2010-05-19

7.  Effects of obesity on lower urinary tract symptoms in Korean BPH patients.

Authors:  Seung Hwan Lee; Joon Chul Kim; Ji-Youl Lee; Jang Hwan Kim; Cheol Young Oh; Seung Wook Lee; Se Jeong Yoo; Byung Ha Chung
Journal:  Asian J Androl       Date:  2009-09-21       Impact factor: 3.285

8.  Inflammatory Signaling Involved in High-Fat Diet Induced Prostate Diseases.

Authors:  Eswar Shankar; Natarajan Bhaskaran; Gregory T MacLennan; Guiming Liu; Firouz Daneshgari; Sanjay Gupta
Journal:  J Urol Res       Date:  2015-01-12

9.  Effect of obesity on International Prostate Symptom Score and prostate volume.

Authors:  Kazım Yelsel; Ergün Alma; Alper Eken; Mehmet Gülüm; Hakan Erçil; Ali Ayyıldız
Journal:  Urol Ann       Date:  2015 Jul-Sep

10.  Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model.

Authors:  Su Kang Kim; Hosik Seok; Hae Jeong Park; Hye Sook Jeon; Sang Wook Kang; Byung-Cheol Lee; Jooil Yi; Sang Yeol Song; Sang Hyub Lee; Young Ock Kim; Joo-Ho Chung
Journal:  BMC Complement Altern Med       Date:  2015-10-22       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.